Demonstrating the value of early economic evaluation alongside clinical trials: Exercise medicine for men with metastatic prostate cancer

被引:4
|
作者
Edmunds, Kim [1 ,2 ]
Scuffham, Paul [1 ,2 ]
Reeves, Penny [3 ,4 ]
Galvao, Daniel A. [5 ,6 ]
Taaffe, Dennis R. [5 ,6 ]
Newton, Robert U. [5 ,6 ]
Spry, Nigel [5 ,7 ]
Joseph, David [5 ,7 ]
Tuffaha, Haitham [8 ]
机构
[1] Griffith Univ, Ctr Appl Hlth Econ, Brisbane, Qld, Australia
[2] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia
[3] Hunter Med Res Inst, New Lambton Hts, NSW, Australia
[4] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia
[5] Edith Cowan Univ, Exercise Med Res Inst, Joondalup, WA, Australia
[6] Edith Cowan Univ, Sch Med & Hlth Sci, Joondalup, WA, Australia
[7] Sir Charles Gairdner Hosp, Dept Radiat Oncol, Nedlands, WA, Australia
[8] Univ Queensland, Ctr Business & Econ Hlth, Brisbane, Qld, Australia
关键词
cost-effectiveness analysis; economic evaluation; exercise medicine; metastatic prostate cancer; value of information analysis;
D O I
10.1111/ecc.13479
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [21] Application of the ASCO value framework to evaluate the clinical and economic value of enzalutamide and apalutamida in the early stages of prostate cancer in Colombia
    Romero, Martin
    Diaz, Andrea
    Sanchez, Karen
    Amaya, Sandra
    Godoy, Fabian
    Rodriguez, David
    ECANCERMEDICALSCIENCE, 2023, 17
  • [22] Men Moving Forward: Incorporating Sexual Health Of Prostate Cancer Survivors In Exercise Trials
    Born, Kathryn A.
    Stolley, Melinda
    Flynn, Kathryn
    Sheean, Patricia
    Kilari, Deepak
    Bylow, Kathryn
    Papanek, Paula
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2023, 55 (09) : 647 - 648
  • [23] Pharmaco-economic evaluation of docetaxel-based chemotherapy in men with metastatic, castration resistant prostate cancer (mCRPC)
    Pfister, D.
    Porres, D.
    Piper, C.
    Thissen, A.
    Heidenreich, A.
    ONKOLOGIE, 2013, 36 : 80 - 81
  • [24] An evaluation of race-based representation among men participating in clinical trials for prostate cancer and erectile dysfunction
    Saltzman, Russell G.
    Zucker, Isaac
    Campbell, Katherine
    Gandhi, Deep A.
    Otiono, Kikachukwu
    Weber, Alexander
    Masterson, Thomas A.
    Ramasamy, Ranjith
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2022, 29
  • [25] AN EVALUATION OF RACE-BASED REPRESENTATION AMONG MEN PARTICIPATING IN CLINICAL TRIALS FOR PROSTATE CANCER AND ERECTILE DYSFUNCTION
    Saltzman, R.
    Zucker, I.
    Campbell, K.
    Gandhi, D.
    Otiono, K.
    Weberl, A.
    Masterson, T.
    Ramasamy, R.
    JOURNAL OF SEXUAL MEDICINE, 2023, 20
  • [26] Clinical utility of FoundationOne tissue molecular profiling in men with metastatic prostate cancer
    Zhu, Jason
    Tucker, Matthew
    Marin, Daniele
    Gupta, Rajan T.
    Healy, Patrick
    Humeniuk, Michael
    Jarvis, Casey
    Zhang, Tian
    McNamara, Megan
    George, Daniel J.
    Wu, Yuan
    Lisi, Stacey
    Armstrong, Andrew J.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (11) : 813.e1 - 813.e9
  • [27] Associations between sarcopenia and clinical outcomes in men with metastatic castrateresistant prostate cancer
    Papadopoulos, Efthymios
    Wong, Andy Kin On
    Law, Sharon Hiu Ching
    Zhang, Lindsey Ze Jing
    Breunis, Henriette
    Emmenegger, Urban
    Alibhai, Shabbir M. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [28] A prostate cancer clinical trials consortium trial of disulfiram (D) in men with nonmetastatic recurrent prostate cancer (PCa)
    Schweizer, Michael Thomas
    Bardia, Aditya
    Blackford, Amanda L.
    Lin, Jianqing
    Armstrong, Andrew J.
    King, Serina
    Rudek, Michelle A.
    Yegnasubramanian, Srinivasan Thomas
    Carducci, Michael Anthony
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [29] Challenges to Recruiting Men on Active Surveillance for Prostate Cancer in Clinical Chemoprevention Trials
    Kumar, Nagi B.
    Bahl, Saira
    Dhillon, Jasreman
    Poch, Michael
    Manley, Brandon
    Li, Roger
    Schell, Michael
    Powsang, Julio
    CANCERS, 2023, 15 (04)
  • [30] EMERGING BIOMARKERS IN METASTATIC CASTRATION RESISTANT PROSTATE CANCER AS EVALUATED IN EARLY PHASE CLINICAL TRIALS: A TARGETED LITERATURE REVIEW
    Lee, L. J.
    Jones, M.
    Timmel, E. E.
    Masten, L.
    Liu, L.
    Andreu-Vieyra, C.
    Serfass, L.
    VALUE IN HEALTH, 2023, 26 (12) : S542 - S542